Dopamine and Parkinson's disease: Is the killer in the house?

Molecular Psychiatry

Volumn 8, Issue 4, 2003, Pages 369-370

  Chesselet, M F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; REACTIVE OXYGEN METABOLITE;

DOPAMINERGIC NERVE CELL; HUMAN; NEUROPROTECTION; NEUROPSYCHIATRY; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

DOPAMINE; HUMANS; NERVE TISSUE PROTEINS; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; SYNUCLEINS;

EID: 0037615219     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001289     Document Type: Note

References (12)

1. Xu J et al. Nat Med 2002; 8: 600-606.
2. Polymeropoulos MH et al. Science 1997; 276: 2045-2047.
3. Spillantini MG et al. Nature 1997; 388: 839-840.
4. Giasson BI et al. Science 2000; 290: 985-989.
5. Cabin DE et al. J Neurosci 2002; 22: 8797-8800.
6. Lashuel HA et al. Nature 2002; 418: 291.
7. Krüger R et al. Trends Mol Med 2002; 8: 236-240.
8. McNaught KS, Jenner P. Neurosci Lett 2001; 297: 191-194.
9. Junn E, Mouradian MM. Neuroscience Letters 2002; 320: 146-150.
10. Conway KA et al. Science 2001; 294: 1346-1349.
11. Weingarten P, Zhou QY. J Neurochem 2001; 77: 776-785.
12. Lotharius J et al. J Biol Chem 2002; 277: 38884-38894.